2289.HK लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 10:37):

Stats
आज की मात्रा	500.00
औसत मात्रा	145 905
बाजार मूल्य	1.45B
EPS	HKD0 ( 2024-03-29 )
अगली कमाई की तारीख	( HKD0 ) 2024-05-20
Last Dividend	HKD0.499 ( 2023-06-29 )
Next Dividend	HKD0 ( N/A )
P/E	26.35
ATR14	HKD0 (0.00%)

Charmacy Pharmaceutical सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Charmacy Pharmaceutical वित्तीय

Annual	2023
राजस्व:	HKD4.40B
सकल लाभ:	HKD292.74M (6.65 %)
EPS:	HKD0.480

FY	2023
राजस्व:	HKD4.40B
सकल लाभ:	HKD292.74M (6.65 %)
EPS:	HKD0.480

FY	2022
राजस्व:	HKD4.18B
सकल लाभ:	HKD268.61M (6.43 %)
EPS:	HKD0.840

FY	2021
राजस्व:	HKD3.79B
सकल लाभ:	HKD237.22M (6.25 %)
EPS:	HKD0.221

Financial Reports:

No articles found.

Charmacy Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.949 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Charmacy Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.03 - low (34.13%) | Divividend Growth Potential Score: 1.039 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.229	2016-11-14
Last Dividend	HKD0.499	2023-06-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.57	--
Avg. Dividend % Per Year	0.00%	--
Score	1.35	--
Div. Sustainability Score	4.03
Div.Growth Potential Score	1.039
Div. Directional Score	2.54	--

Next Divdend (Est)
(2024-10-07)

HKD0.572 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.35

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2866.HK	Ex Dividend Junior	2023-07-06	Sporadic	0.00%
1459.HK	Ex Dividend Junior	2023-05-25	Annually	0.00%
0536.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
8037.HK	No Dividend Player	2023-05-19	Sporadic	0.00%
1988.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
1065.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0133.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
3658.HK	Ex Dividend Knight	2023-09-28	Annually	0.00%
1606.HK	Ex Dividend Junior	2023-06-30	Annually	0.00%
0662.HK	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0158	1.200	9.47	10.00	[0 - 0.3]
returnOnEquityTTM	0.0877	1.500	-0.136	-0.205	[0.1 - 1]
payoutRatioTTM	0.233	-1.000	7.67	-7.67	[0 - 1]
currentRatioTTM	1.074	0.800	9.63	7.71	[1 - 3]
quickRatioTTM	0.611	0.800	-1.113	-0.890	[0.8 - 2.5]
cashRatioTTM	0.242	1.500	9.77	10.00	[0.2 - 2]
debtRatioTTM	0.393	-1.500	3.46	-5.19	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-2.12	2.00	-0.706	-1.412	[0 - 30]
freeCashFlowPerShareTTM	-2.40	2.00	-1.199	-2.40	[0 - 20]
debtEquityRatioTTM	2.13	-1.500	1.469	-2.20	[0 - 2.5]
grossProfitMarginTTM	0.0665	1.000	-2.23	-2.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.0247	1.000	-1.507	-1.507	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.179	1.000	-2.11	-2.11	[0.2 - 2]
assetTurnoverTTM	1.356	0.800	4.29	3.43	[0.5 - 2]
Total Score				4.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	26.58	1.000	7.42	0	[1 - 100]
returnOnEquityTTM	0.0877	2.50	-0.0877	-0.205	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.40	2.00	-0.799	-2.40	[0 - 30]
dividendYielPercentageTTM	7.51	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-2.12	2.00	-0.706	-1.412	[0 - 30]
payoutRatioTTM	0.233	1.500	7.67	-7.67	[0 - 1]
pegRatioTTM	-2.47	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0520	1.000	-3.80	0	[0.1 - 0.5]
Total Score				1.039

Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.